⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct

Official Title: Study Of Gemcitabine, Leukovorin, And Fluorouracil Used To Treat Locally Advanced And Metastatic Pancreatic And Biliary Adenocarcinomas

Study ID: NCT00010088

Study Description

Brief Summary: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine, leucovorin, and fluorouracil in treating patients who have locally advanced or metastatic cancer of the pancreas or bile duct.

Detailed Description: OBJECTIVES: I. Determine the response rate, in terms of WHO objectives and clinical benefit, in patients with locally advanced or metastatic pancreatic or biliary adenocarcinoma treated with gemcitabine, leucovorin calcium, and fluorouracil. II. Determine the tolerance of this regimen in this patient population. III. Determine the survival without disease progression in patients treated with this regimen. IV. Determine the overall survival in patients treated with this regimen. OUTLINE: This is a multicenter study. Patients receive leucovorin calcium IV over 2 hours followed by fluorouracil IV over 24 hours on day 1 followed by gemcitabine IV over 80-150 minutes on day 2. Treatment repeats every 2 weeks for a minimum of 6 courses in the absence of disease progression or unacceptable toxicity. Patients achieving complete response may continue chemotherapy for up to 1 year. Patients with locally advanced disease after 3 months of chemotherapy may receive concurrent radiotherapy with chemotherapy for 5 weeks, or may undergo surgical resection. Fluorouracil-based chemotherapy (with or without radiotherapy) may then resume after surgery. Patients are followed for survival. PROJECTED ACCRUAL: A total of 14-39 patients will be accrued for this study.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Clinique De Rochebelle, Ales, , France

Centre Hospitalier Victor Dupouy, Argenteuil, , France

Centre D'Oncologie Du Pays-Basqu, Bayonne, , France

C.H.G. Beauvais, Beauvais, , France

Institut Bergonie, Bordeaux, , France

CMC Bligny, Briis Sous Forges, , France

Clinique Saint-Jean, Cagne-sur-Mer, , France

Hopital Fontenoy, Chartres, , France

Hopital Beaujon, Clichy, , France

Hopital Drevon, Dijon, , France

Centre D'Oncologie Dunkerquois, Dunkerque, , France

Polyclinique De La Foret, Fontaineblea, , France

CHR de Grenoble - La Tronche, Grenoble, , France

Centre De Charlebourg, La Garenne Colombes, , France

Clinique Du Cap D'OR, LA Seyne Sur Me, , France

Hopital Andre Mignot, Le Chesnay, , France

Hopital de la Croix Rousse, Lyon, , France

Assistance Publique Hopitaux de Marseille Hopitaux Sud, Marseille, , France

Hopital Notre-Dame de Bon Secours, Metz, , France

Hopital Clinique Claude Bernard, Metz, , France

Intercommunal Hospital, Montfermeil, , France

Centre Hospitalier De Moulins Yzeure, Moulins, , France

Centre Hospitalier de Mulhouse, Mulhouse, , France

CHR Hotel Dieu, Nantes, , France

American Hospital of Paris, Neuilly Sur Seine, , France

CHR D'Orleans - Hopital de la Source, Orleans, , France

Hopital Boucicaut, Paris Cedex, , France

Hopital Laennec, Paris, , France

Clinique Du Mont Louis, Paris, , France

Hopital Rothschild, Paris, , France

Hopital Saint Joseph, Paris, , France

L'Institut Mutualiste Montsouris Jourdan, Paris, , France

Hopital Saint-Louis, Paris, , France

Hopital Saint Antoine, Paris, , France

Hopital Tenon, Paris, , France

Hopital De La Croix, Paris, , France

Clinique Bizet, Paris, , France

Hopital Haut Leveque, Pessac, , France

Clinique Ste-Marie, Pontoise, , France

Hopital Claude Gallien, Quincy Sous Senart, , France

Polyclinique De Courlancy, Reims, , France

Oncologie Medicale, Saint Jean, , France

Centre du Rouget, Sarcelles, , France

C.H. Senlis, Senlis, , France

Centre Hospitalier Intercommunal Toulon - La Seyne/Mer, Toulon - Cedex, , France

Clinique Pasteur, Toulouse, , France

Polyclinique Flemming, Tours, , France

Centre Saint-Yves, Vannes, , France

Institut Gustave Roussy, Villejuif, , France

Hopital de la Ville D'Esch-sur-Alzette, Esch-sur-Alzette, , Luxembourg

Contact Details

Name: Christophe Louvet, MD, PhD

Affiliation: Hopital Saint Antoine

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: